| |
Patients n = 20 (18 M, 2 F)
|
Controls n = 20 (14 M, 6 F)
|
Group Difference
|
|---|
| |
M
|
SD
|
M
|
SD
| |
|---|
|
Age (years)
|
34.8
|
7.2
|
36.6
|
6.8
|
t(38) = 0.81, p > .1
|
|
WRAT-R IQ
|
102.7
|
10.6
|
105.4
|
8.9
|
t(38) = 0.85, p > .1
|
|
WAIS-R IQ
|
87.6
|
8.2
|
105.9
|
10.8
|
t(38) = 6.04, p < .001
|
|
Digit span: Total
|
13.2
|
3.4
|
18.3
|
4.3
|
t(38) = 3.81, p < .001
|
|
Digit span: Forward
|
7.1
|
1.8
|
9.2
|
2.4
|
t(38) = 3.03, p < .01
|
|
Digit span: Backward
|
6.1
|
2.3
|
9.1
|
2.5
|
t(38) = 4.02, p < .001
|
|
Neuroleptic medication
|
19
| |
0
| | |
|
clozapine/olanzapine
|
14
| |
-
| | |
|
risperidone
|
7
| |
-
| | |
|
high potency drug*
|
1
| |
-
| | |
|
anticholinergics
|
1
| |
-
| | |
|
adjunctives**
|
10
| |
-
| | |
- * = haloperidol ** = lithium, depakote, sertraline, lorazepam, venlafaxine, clonazepam, buspirone
